In the BioHarmony Drug Report Database
Metaxalone
Metaxalone, Skelaxin (metaxalone) is a small molecule pharmaceutical. Metaxalone was first approved as Metaxalone on 1982-01-01. It is used to treat muscle cramp, muscle rigidity, muscle spasticity, myositis, and pain amongst others in the USA. Skelaxin’s patents are valid until 2026-02-06 (FDA).
Trade Name
|
Metaxalone, Skelaxin |
|---|---|
Common Name
|
metaxalone |
ChEMBL ID
|
CHEMBL1079604 |
Indication
|
muscle cramp, muscle rigidity, muscle spasticity, myositis, pain, spasm |
Drug Class
|
Image (chem structure or protein)